Position in AMGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$524,349
+$13,463 QoQ
Shares Held
1,448
-0.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#2,145
of 3,140 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Capital Asset Advisory Services LLC holds $29,712,872 across 11 Drug Manufacturers - General names. AMGN ranks #7 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
26,233 | $6,662,395 | |
| 2 | LLY |
ELI LILLY & Co
|
4,985 | $5,979,159 | |
| 3 | ABBV |
AbbVie Inc.
|
22,814 | $5,740,914 | |
| 4 | PFE |
Pfizer Inc
|
138,613 | $3,337,801 | |
| 5 | MRK |
Merck & Co., Inc.
|
23,955 | $3,078,217 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
46,813 | $2,697,365 | |
| 7 | AMGN |
Amgen Inc
This page
|
1,448 | $524,349 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
4,064 | $513,445 |
All Filings in AMGN
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $524,349 | 1,448 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $510,886 | 1,452 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $504,384 | 1,541 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $439,103 | 1,556 | Shares | Sole | 2025-10-02 | |
| 2025-06-30 | $434,171 | 1,555 | Shares | Sole | 2025-07-07 | |
| 2025-03-31 | $508,138 | 1,631 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $504,859 | 1,937 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $653,119 | 2,027 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $539,913 | 1,728 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $500,118 | 1,759 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $426,845 | 1,482 | Shares | Sole | 2024-01-09 | |
| 2023-03-31 | $355,372 | 1,470 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $404,728 | 1,541 | Shares | Sole | 2023-03-08 | |
| 2022-09-30 | $347,116 | 1,540 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $362,030 | 1,488 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $355,717 | 1,471 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $322,606 | 1,434 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $288,778 | 1,358 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $902,362 | 3,702 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $962,894 | 3,870 | Shares | Sole | 2021-05-13 | |
| 2020-06-30 | $871,974 | 3,697 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $645,897 | 3,186 | Shares | Sole | 2020-05-18 | |
| No filing history on record for this holder in this stock. | ||||||